پن کیا گیا ٹویٹ
As CymaBay is now part of @GileadSciences, this account is no longer active. We look forward to advancing our shared mission. Thank you for your support.
English
CymaBay Therapeutics
443 posts
CymaBay Therapeutics
@CymaBay
We are a global clinical-stage biopharma company developing solutions for patients with liver diseases.
newark, ca شامل ہوئے Haziran 2019
192 فالونگ423 فالوورز
Primary biliary cholangitis (PBC) is a rare, chronic, autoimmune liver disease that progressively destroys the liver’s bile ducts. Learn more about PBC here: bit.ly/3KRMfjT
English
Learn more about the unmet needs in #PrimaryBiliaryCholangitis today and how @GileadSciences is working to create a healthier future for people living with #PBC and #LiverDisease.
Gilead Sciences@GileadSciences
Learn about the unmet needs of people living with #PrimaryBiliaryCholangitis (PBC) and the advances in research that aim to improve liver health and quality of life.
English
As #EASLCongress closes, we are grateful to have shared our latest findings and connected with stakeholders from across #PrimaryBiliaryCholangitis and #hepatology as we continue working to improve PBC care. Thanks, @EASLnews, for bringing this incredible community together!
English
At @EASLnews #EASLCongress, we will share interim long-term data from our ASSURE study of our investigational therapy in people living with #PrimaryBiliaryCholangitis. Learn more: bit.ly/4eadqnl
English
The myth that #PrimaryBiliaryCholangitis doesn’t impact men can delay diagnosis. This #MensHealthMonth, we encourage men to prioritize their #LiverHealth by talking to a doctor if experiencing common PBC symptoms like intense itch or fatigue. Learn more: bit.ly/4e7bbkH
English
We are looking forward to #EASLCongress 2024 next week and meeting with hepatology experts from around the world as we work to advance care for people living with #PrimaryBiliaryCholangitis. Please visit: bit.ly/3QV9n4d
English
Thank you @DDWMeeting for another impactful meeting. It was great to connect with experts from across the U.S. passionate about advancing care for people living with #LiverDiseases and #PrimaryBiliaryCholangitis. #DDW2024
English
We are proud to present our latest research in primary biliary cholangitis at #EASLCongress 2024 as part of Gilead’s research across liver diseases.
Learn more at: bit.ly/3UMVUg6
Gilead Sciences@GileadSciences
#GileadNews: We’ll share the latest data from our liver disease franchise at #EASLCongress, underlining our drive for life-changing science to create healthier futures for people living with liver disease. Read more: gilead.inc/4ayTiIB
English
On #ClinicalTrialsDay we join @ACRPDC to recognize the critical progress made by clinical research and thank every participant that has taken part in a clinical study to help advance care in #PrimaryBiliaryCholangitis. Learn about our ongoing studies: bit.ly/3ypaD9u
English
At @DDWMeeting #DDW2024, we will share results from our ongoing ASSURE study demonstrating further evidence of the efficacy and safety profile of our investigational therapy for #PrimaryBiliaryCholangitis. Learn more: bit.ly/3ymaQKK
English
This #WomensHealthMonth, we encourage women to prioritize their #LiverHealth and speak up if experiencing itch or fatigue, symptoms of #PrimaryBiliaryCholangitis, a chronic, autoimmune liver disease. Learn more here: bit.ly/47LQ96P
English
Last week, we welcomed some new recruits to our team on #BringYourChildToWorkDay. It was a day full of fun activities and #STEM experiments to inspire us all. They did a great job in their final presentation!
English
On #WorldLiverDay, we recognize the liver's central role in a myriad of vital functions in the body. With chronic liver disease on the rise, education surrounding #LiverHealth is so important. Watch to learn more about #PrimaryBiliaryCholangitis, a rare liver disease.
English
“Empowering Connections in PBC” was the theme at this year's @PBCers conference. Onsite we learned from people living with #PrimaryBiliaryCholangitis and their families and were so inspired by their stories. For resources on getting support, please visit: bit.ly/3xzzSFH
English
At the #pbcSummit we joined advocates from around the world working to improve the lives of people with #PrimaryBiliaryCholangitis. Their passion and ideas inspired us and we left with lots to consider for our work ahead. Thank you @PBCFoundation for leading this impactful event!
English
#DYK that more than 50% of people with autoimmune diseases, like #PrimaryBiliaryCholangitis (PBC), can experience depression and anxiety? Learn more about the importance of holistic health approaches for people with PBC: bit.ly/3Jh1TEz
English
We are pleased to be onsite at the @CLDFoundation #LiverConnect Conference to discuss the latest research in #PrimaryBiliaryCholangitis. Check out the program: bit.ly/3IKpw8b
English
Today we become a wholly owned subsidiary of @GileadSciences. We’ve always been dedicated to advancing life-changing treatments, and together we’ll be able to further our commitment to improve the lives of people with liver disease. bit.ly/3TKiEOz
English
We are pleased to be onsite with the European liver community at the Paris Hepatology Conference discussing the impact of Primary Biliary Cholangitis (PBC). For more information, visit: bit.ly/49R2991
#HybridPHC2024
English